'Evolve the organization:' Inside Syneos Health's $7.1B private equity deal

The announcement of the Syneos Health sale comes nearly six years after Syneos Health was created by the $7.4 billion merger of INC Research and inVentiv Health in August 2017. Here's a detailed look at the deal.

Related Keywords

Washington ,United States ,John Dineen ,April Syneos ,Jim Momtazee ,Ramzi Musallam ,Marc Steinberg ,World Vaccine Congress ,Catalyst Vaccine Network ,Syneos Health ,Elliott Investment Management ,Patient Square Capital ,Veritas Capital ,Patient Square ,Nventiv Health ,Vaccine Industry Excellence Award ,Best Contract Research Organization ,Vaccine Congress ,